1. Home
  2. AII vs ZURA Comparison

AII vs ZURA Comparison

Compare AII & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Integrity Insurance Group Inc.

AII

American Integrity Insurance Group Inc.

N/A

Current Price

$28.91

Market Cap

502.6M

Sector

Finance

ML Signal

N/A

Logo Zura Bio Limited

ZURA

Zura Bio Limited

N/A

Current Price

$0.93

Market Cap

455.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AII
ZURA
Founded
2006
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
502.6M
455.4M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
AII
ZURA
Price
$28.91
$0.93
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
★ $31.50
$8.00
AVG Volume (30 Days)
180.9K
★ 6.7M
Earning Date
11-10-2026
10-27-2026
Dividend Yield
★ 3.45%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 4.20
N/A
Revenue
★ $276,485,000.00
N/A
Revenue This Year
$56.63
N/A
Revenue Next Year
$25.72
N/A
P/E Ratio
$7.03
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.19
$0.93
52 Week High
$32.21
$7.25

Technical Indicators

Market Signals
Indicator
AII
ZURA
Relative Strength Index (RSI) 56.04 24.68
Support Level $25.16 $0.93
Resistance Level $32.21 $5.97
Average True Range (ATR) 1.38 0.24
MACD -0.01 -0.18
Stochastic Oscillator 49.43 0.51

Price Performance

Historical Comparison
AII
ZURA

About AII American Integrity Insurance Group Inc.

American Integrity Insurance Group Inc is engaged in the property and casualty insurance business. It provides personal residential property insurance for single-family homeowners and condominium owners as well as coverage for vacant dwellings and investment properties, predominantly in Florida. The Company's property and casualty insurance is currently offered in Florida, North Carolina, South Carolina, and Georgia.

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.

Share on Social Networks: